New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
LifeMD, Inc.
LFMDP
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

965M

Medical - Pharmaceuticals

Next Earning date - 10 Mar 2025

965M

Medical - Pharmaceuticals

Next Earning date - 10 Mar 2025

22.29USD

Shape0.34 ( 1.55%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

77
favorite-chart

Volume Buzz

-31%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated February 15, 2025
1W -1.15 % 1M 0.18 % 3M 0.41 % 1Y 25.93 %

Key Metrics

Shape
  • Market Cap

    965.43M


  • Shares Outstanding

    14.88M


  • Share in Float


  • Dividende

    2.21876


  • Earning Date

    10 Mar 2025


  • Price Target

    22.29


  • Average Volume

    2023


  • Beta

    1.497


  • Range

    18.75-25


  • Industry

    Medical - Pharmaceuticals


  • Website

    https://www.lifemd.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

LFMDP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$257M

Shape539%

2025-Revenue

0

$112M

Shape-5148%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.42
vs -0.55

Q3.22

arrow
arrow

N/A

-0.24
vs -0.47

Q4.22

arrow
arrow

N/A

-0.37
vs -0.59

Q1.23

arrow
arrow

N/A

-0.32
vs -0.44

Q2.23

arrow
arrow

N/A

-0.21
vs -0.42

Q3.23

arrow
arrow

N/A

-0.18
vs -0.24

Q4.23

arrow
arrow

N/A

-0.10
vs -0.37

Q1.24

arrow
arrow

N/A

-0.17
vs -0.32

Q2.24

arrow
arrow

N/A

-0.17
vs -0.21

Q3.24

arrow
arrow

N/A

-0.14
vs -0.18

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+3%

28.1M  vs 27.4M

Q1.23

arrow
arrow

+14%

33.1M  vs 29M

Q2.23

arrow
arrow

+18%

35.9M  vs 30.5M

Q3.23

arrow
arrow

+23%

38.6M  vs 31.4M

Q4.23

arrow
arrow

+60%

44.9M  vs 28.1M

Q1.24

arrow
arrow

+33%

44.1M  vs 33.1M

Q2.24

arrow
arrow

+41%

50.7M  vs 35.9M

Q3.24

arrow
arrow

+4%

40.3M  vs 38.6M

Q4.24

arrow
arrow

+28%

57.4M  vs 44.9M

Q1.25

arrow
arrow

+35%

59.4M  vs 44.1M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+169%

1.69
vs -2.17

Q1.23

arrow
arrow

+138%

1.38
vs 1.69

Q2.23

arrow
arrow

+61%

0.61
vs 1.38

Q3.23

arrow
arrow

+48%

0.48
vs 0.61

Q4.23

arrow
arrow

-106%

-1.06
vs 0.48

Q1.24

arrow
arrow

+801%

8.01
vs -1.06

Q2.24

arrow
arrow

+163%

1.63
vs 8.01

Q3.24

arrow
arrow

+77%

0.77
vs 1.63

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News